Kelix Bio

Acquired

kelixbio.com

Abu Dhabi, United Arab Emirates · Founded 2020 · $200.0M raised

Headquarters
Abu Dhabi
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$200.0M
Last Round
$200.0M Private EquityJan 2022
Rounds
2
Acquisition Date
Mar 2024

About

KELIX bio is an emerging markets-focused specialty generic biopharmaceutical company providing complex generics and high-complexity products to underserved populations across 40+ countries. Established in November 2020 and now a wholly owned subsidiary of Abu Dhabi sovereign wealth fund Mubadala Investment Company, the company operates a buy-and-build model, having expanded rapidly through acquisitions of manufacturing entities in India, Egypt, Malta, Morocco, and the UAE. KELIX bio competes through innovation and cost leadership in the specialty generics sector, with a focus on sterile liquid and lyophilized pharmaceuticals including antineoplastic products.

Summary

Kelix Bio is a Biotech company based in Abu Dhabi, United Arab Emirates, founded in 2020. It has raised $200.0M in total across 2 rounds, most recently a $200.0M Private Equity round in Jan 2022. Investors include Development Partners International, Mubadala Investment Company and British International Investment.

Funding History

AcquisitionMar 2024

Sign up to see all 3 rounds

Private Equity through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kelix Bio on Indexed.vc
<a href="https://indexed.vc/companies/kelix-bio"><img src="https://indexed.vc/api/badge/company/kelix-bio" alt="Kelix Bio on Indexed.vc" width="260" height="76" /></a>